[go: up one dir, main page]

NO880520D0 - Fremgangsmaate for fremstilling av et cholestyraminpreparat - Google Patents

Fremgangsmaate for fremstilling av et cholestyraminpreparat

Info

Publication number
NO880520D0
NO880520D0 NO880520A NO880520A NO880520D0 NO 880520 D0 NO880520 D0 NO 880520D0 NO 880520 A NO880520 A NO 880520A NO 880520 A NO880520 A NO 880520A NO 880520 D0 NO880520 D0 NO 880520D0
Authority
NO
Norway
Prior art keywords
preparing
procedure
cholestyramine
preparation
cholestyramine preparation
Prior art date
Application number
NO880520A
Other languages
English (en)
Other versions
NO880520L (no
Inventor
Gary J Schuelz
Original Assignee
Dow Chemical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dow Chemical Co filed Critical Dow Chemical Co
Publication of NO880520D0 publication Critical patent/NO880520D0/no
Publication of NO880520L publication Critical patent/NO880520L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO880520A 1987-02-09 1988-02-05 Fremgangsmaate for fremstilling av et cholestyraminpreparat NO880520L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1247087A 1987-02-09 1987-02-09
US14069688A 1988-01-04 1988-01-04

Publications (2)

Publication Number Publication Date
NO880520D0 true NO880520D0 (no) 1988-02-05
NO880520L NO880520L (no) 1988-08-10

Family

ID=26683596

Family Applications (1)

Application Number Title Priority Date Filing Date
NO880520A NO880520L (no) 1987-02-09 1988-02-05 Fremgangsmaate for fremstilling av et cholestyraminpreparat

Country Status (6)

Country Link
EP (1) EP0278464A1 (no)
JP (1) JPS63290822A (no)
AU (1) AU610556B2 (no)
CA (1) CA1313135C (no)
DK (1) DK66988A (no)
NO (1) NO880520L (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL85632A (en) * 1987-03-10 1991-08-16 Ciba Geigy Ag Hypocholesterolaemic gel formulation containing a pharmaceutically acceptable non-digestible anion exchange resin
DE3808191C2 (de) * 1988-03-11 1998-08-06 Astra Chem Gmbh Colestyramin enthaltende pharmazeutische Zusammensetzung
IL95574A (en) * 1989-09-09 1994-11-11 Knoll Ag Colestyramine preparation
US5576306A (en) * 1991-03-01 1996-11-19 Dow Chemical Company Pharmaceutical compositions and uses of water-soluble, high-viscosity grade cellulose ethers
US5721221A (en) * 1991-03-08 1998-02-24 Regents Of The University Of Minnesota Lowering blood cholesterol levels using water soluble cellulose ethers
AU3812893A (en) * 1992-03-20 1993-10-21 Procter & Gamble Company, The Anion exchange resin compositions
US5942550A (en) * 1996-01-25 1999-08-24 The Procter & Gamble Company Cholesterol lowering drink mix compositions
US6280717B1 (en) 1998-07-31 2001-08-28 Nikken Chemicals Co., Ltd. Cation exchange resin preparation
EP1667658A2 (en) * 2003-09-03 2006-06-14 Mallinckrodt Inc. Granular sustained release preparation and production thereof
CA2815749C (en) 2010-11-04 2019-12-03 Albireo Ab Ibat inhibitors for the treatment of liver diseases
KR20220082931A (ko) 2014-06-25 2022-06-17 이에이 파마 가부시키가이샤 고형 제제 및 그의 착색 방지 또는 착색 감소 방법
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
US10786529B2 (en) 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
CN108601739B (zh) * 2016-02-09 2022-01-04 阿尔比里奥公司 考来烯胺丸剂及其制备方法
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
RU2750944C2 (ru) * 2016-02-09 2021-07-06 Альбирео Аб Пероральный состав холестирамина и его применение
WO2019032027A1 (en) * 2017-08-09 2019-02-14 Albireo Ab CHOLESTYRAMINE TABLETS, ORAL FORMULATIONS OF CHOLESTYRAMINE AND THEIR USE
EP3664781A1 (en) 2017-08-09 2020-06-17 Albireo AB Cholestyramine granules, oral cholestyramine formulations and use thereof
CA3100113A1 (en) 2018-06-05 2019-12-12 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
US10793534B2 (en) 2018-06-05 2020-10-06 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
SG11202012151XA (en) 2018-06-20 2021-01-28 Albireo Ab Crystal modifications of odevixibat
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
DK3921028T3 (da) 2019-02-06 2023-01-23 Albireo Ab Benzothiadiazepinforbindelser og anvendelse deraf som galdesyremodulatorer
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
EP4069247A1 (en) 2019-12-04 2022-10-12 Albireo AB Benzothiadiazepine compounds and their use as bile acid modulators
BR112022010505A2 (pt) 2019-12-04 2022-09-06 Albireo Ab Compostos de benzotia(di)azepina e seu uso como moduladores do ácido biliar
JP2023504643A (ja) 2019-12-04 2023-02-06 アルビレオ・アクチボラグ ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
JP2023504647A (ja) 2019-12-04 2023-02-06 アルビレオ・アクチボラグ ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
EP4188541B1 (en) 2020-08-03 2024-12-25 Albireo AB Benzothia(di)azepine compounds and their use as bile acid modulators
JP2023549226A (ja) 2020-11-12 2023-11-22 アルビレオ エービー 進行性家族性肝内胆汁うっ滞症（ｐｆｉｃ）を処置するためのオデビキシバット
AU2021390172A1 (en) 2020-12-04 2023-06-22 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
EP4094753A1 (en) 2021-05-27 2022-11-30 Manfred Stangl Perforated cholestyramine capsule

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3974272A (en) * 1972-09-01 1976-08-10 Merck & Co., Inc. Palatable cholestyramine coacervate compositions
NL7311319A (no) * 1972-09-01 1974-03-05
FR2525474A1 (fr) * 1982-04-26 1983-10-28 Roussel Uclaf Nouvelle forme pharmaceutique orale de clometacine
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom

Also Published As

Publication number Publication date
NO880520L (no) 1988-08-10
DK66988A (da) 1988-08-10
EP0278464A1 (en) 1988-08-17
AU610556B2 (en) 1991-05-23
AU1126688A (en) 1988-08-11
DK66988D0 (da) 1988-02-09
JPS63290822A (ja) 1988-11-28
CA1313135C (en) 1993-01-26

Similar Documents

Publication Publication Date Title
NO880520L (no) Fremgangsmaate for fremstilling av et cholestyraminpreparat
NO173213C (no) Fremgangsmaate for fremstilling av et preparat omfattende et liposom
NO882103D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
NO881044L (no) Fremgangsmaate for fremstilling av en tiazepinforbindelse.
NO170516C (no) Fremgangsmaate for fremstilling av en formulering av beclomethasondipropionat
NO812827L (no) Fremgangsmaate for fremstilling av et bacampicillinpreparat
DK686187D0 (da) Veterinaert praeparat
NO169970C (no) Fremgangsmaate for fremstilling av et vaskepulver
NO934897D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
NO172447C (no) Fremgangsmaate for fremstilling av b-avermectiner
PT91631A (pt) A process for the preparation of cyclic graf-analogs ii
FI883916A0 (fi) Vesikovetteinen polymeerivalmiste
NO901232L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
NO171792C (no) Fremgangsmaate for fremstilling av en friradikal-addisjonspolymer
NO870866D0 (no) Fremgangsmaate for fremstilling av et terapeutisk kombinasjonspreparat.
GB8719093D0 (en) Fibre preparation
NO172442C (no) Fremgangsmaate for fremstilling av en lavere alkenpolymer
NO171910C (no) Fremgangsmaate for fremstilling av 1-alkyl-5-nitroimidazoler
IT8922190A0 (it) Procedimento per preparare n-fosfonometilglicina
NO170425C (no) Fremgangsmaate for fremstilling av en kopolymer
NO171581C (no) Fremgangsmaate for fremstilling av et soppsmaksmiddel
NO902460D0 (no) Fremgangsmaate for fremstilling av en natriumpolyacrylatgel
NO172095C (no) Framgangsmaate for framstilling av sondenaering
NO882883D0 (no) Fremgangsmaate for fremstilling av et piperidinyl-cyklopentylheptensyre-derivat.
NO874539D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat